Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease. (MAD0004J08)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04932850
Recruitment Status : Active, not recruiting
First Posted : June 21, 2021
Last Update Posted : June 21, 2021
Cross Research S.A.
Information provided by (Responsible Party):
Toscana Life Sciences Sviluppo s.r.l.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 2021
Estimated Study Completion Date : October 2021